… This tutorial describes the development of a population pharmacokinetic (Pop PK) analysis
guidance within Pfizer, which strives for improved consistency and efficiency, and a more …

… pharmacokinetic parameters in this population. The objective of the present study was to
develop a population pharmacokinetic … covariates on meropenem pharmacokinetics. In addition…

… The clinical pharmacology profile of nivolumab was analyzed by a population pharmacokinetics
model that assessed covariate effects on nivolumab concentrations in 1,895 patients …

… disease population. It was the aim of this study to evaluate its population pharmacokinetics
in … colitis and characterize patient covariates that affect its disposition in this population. …

… of an analysis themselves. Initially we introduce the general framework of population analysis
and … We then follow-up with specific details on how to interpret population analyses for the …

… Pharmacokinetic population approaches using sparse sampling may resolve this issue. The
pharmacokinetics … published studies concerning population pharmacokinetic approaches in …

… This report describes the results of a population pharmacokinetic analysis characterizing
the … The primary aim of our analysis was to construct a refined pharmacokinetic model for …

OBJECTIVE To present a framework within which population pharmacokinetic (PPK) studies
should be designed and analyzed and discuss the application of developed PPK models. …

… For population pharmacokinetic analysis of multiple oral … that traditional population
pharmacokinetic analysis methods … of initially estimating population pharmacokinetic parameters, …

… The objective of this analysis was to describe the pharmacokinetic characteristics of
anidulafungin in patients with serious fungal disease based on pharmacokinetic data collected …